Insulin: here's the fair price
This is what US pharmacies pay, on average, for insulin. Use it to spot a fair cash price, and feel good about asking for one.
Insulin Lispro 100 Unit/Ml Vl
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| INSULIN LISPRO 100 UNIT/ML VLGeneric | $2.40 per mL | n/a | 10/21/2026 |
| INSULIN GLARGINE-YFGN U100 PENGeneric | $2.90 per mL | n/a | 10/21/2026 |
| INSULIN GLARGINE-YFGN U100 VLGeneric | $6.09 per mL | n/a | 10/21/2026 |
| INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIALGeneric | $6.95 per mL | n/a | 05/20/2026 |
| INSULIN ASPART 100 UNIT/ML VLGeneric | $6.95 per mL | n/a | 05/20/2026 |
| INSULIN ASPART PENFILL 100 UNIT/ML CARTRIDGEGeneric | $8.57 per mL | n/a | 05/20/2026 |
| INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 FLEXPENGeneric | $8.93 per mL | n/a | 05/20/2026 |
| INSULIN ASPART FLEXPEN 100 UNIT/ML PENGeneric | $8.96 per mL | n/a | 05/20/2026 |
| INSULIN LISPRO JR 100 UNIT/ML KWIKPENGeneric | $10.19 per mL | n/a | 10/21/2026 |
| INSULIN LISPRO 100 UNIT/ML KWIKPENGeneric | $10.19 per mL | n/a | 10/21/2026 |
| INSULIN LISPRO MIX 75-25 KWKPNGeneric | $10.20 per mL | n/a | 10/21/2026 |
| INSULIN DEGLUDEC 100 UNIT/ML VIALGeneric | $11.34 per mL | n/a | 05/20/2026 |
| INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PENGeneric | $11.39 per mL | n/a | 05/20/2026 |
| INSULIN DEGLUDEC FLEXTOUCH 200 UNIT/ML PENGeneric | $22.74 per mL | n/a | 05/20/2026 |
| INSULIN GLARGINE MAX SOLO U300Generic | $26.96 per mL | n/a | 10/21/2026 |
| INSULIN GLARGINE SOLOSTAR U300Generic | $26.99 per mL | n/a | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE ADMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )
Common side effects (FDA label)
6 ADVERSE REACTIONS The following adverse reactions are discussed elsewhere: Hypoglycemia [see Warnings and Precautions (5.3) ] Hypoglycemia Due to Medication Errors [see Warnings and Precautions (5.4) ] Hypersensitivity Reactions [see Warnings and Precautions (5.5) ] Hypokalemia [see Warnings and Precautions (5.6) ] Adverse reactions associated with ADMELOG include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, and rash. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact sanofi-aventis at 1-800-633-1610 or FDA at 1-800-FDA-1088 or...
Drug interactions (from the label)
7 DRUG INTERACTIONS Table 2 presents clinically significant drug interactions with ADMELOG. Table 2: Clinically Significant Drug Interactions with ADMELOG Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. Intervention: Dose adjustment and increased frequency of glucose monitoring may be required when ADMELOG is concomitantly administered with these drugs. Drugs That May Decrease the Blood Glucose Lowering Effect of ADMELOG Drugs:...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS Never share an ADMELOG SoloStar disposable prefilled pen or syringe between patients, even if the needle is changed. ( 5.1 ) Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Make changes to a patient's insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) under close medical supervision with increased frequency of blood glucose monitoring. ( 5.2 ) Hypoglycemia: May be life-threatening. Monitor blood glucose and increase monitoring frequency with changes to insulin dosage, use of glucose lowering medications, meal pattern, physical activity; in patients with renal or hepatic impairment; and in...
Source: FDA drug label via openFDA, label effective 2025-06-04. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.